SIGMA2026 Sponsors
We would like to express our sincere thanks to our industry partners whose support made the very first SIGMA meeting possible.
Silver Sponsors
Advanced Ophthalmic Innovations Pte Ltd
BAUSCH+LOMB
Topcon
Bronze Sponsors
Alcon
Clinico Instrument Co., Ltd.
Earn Will Creation Limited
Gaush Meditech ltd
Santen
Topcon
Company Profile:
Topcon Healthcare SEA is committed to delivering advanced ophthalmic solutions to the Southeast Asian region. With a mission to advance eye health through innovation and technology, Topcon provides a comprehensive suite of diagnostic instruments tailored for modern clinical and research needs.
Alcon
Company Profile:
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at our website.
Clinico Instrument Co., Ltd.
Company Profile:
Clinico Group is a Taiwan-based company specializing in the distribution of ophthalmic devices throughout China, Taiwan, Hong Kong, Australia, and Southeast Asia. With decades of experience and strategic partnerships, Clinico supports clinicians and institutions in delivering superior eye care.
Santen
Company Profile:
Santen is a global specialized pharmaceutical company focused exclusively on ophthalmology. With over a century of experience and a presence in more than 60 countries, Santen delivers innovative therapies and solutions that protect and restore vision. Guided by a robust research and development program, Santen addresses unmet needs across a spectrum of eye conditions, helping patients around the world see the future more clearly.
BAUSCH+LOMB
Company Profile:
Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions. With a rich history spanning over 165 years, Bausch + Lomb offers the world’s most comprehensive portfolio of eye health products. These include contact lenses and lens care products, ophthalmic pharmaceuticals, over-the-counter eye care products, and ophthalmic surgical devices and instruments. Bausch + Lomb continues to drive innovation that helps people see better to live better.
Earn Will Creation Limited
Company Profile:
Earn Will Creation Limited was founded by professionals with over a decade of experience in the medical field. With a strong reputation and proven expertise in the sales and maintenance of medical equipment and consumable products, we have built lasting trust among both overseas suppliers and valued customers.
We are proud to represent and support a wide range of internationally recognized brands, including:
- TOPCON ophthalmic equipment from Japan, Europe, and America
- iCare tonometers from Finland
- Rocket respiratory products from the United Kingdom
- Keeler ophthalmic equipment from the United Kingdom
- ASICO ophthalmic products from the United States
- Brumaba operating tables from Germany
Our mission is to provide comprehensive solutions tailored to the needs of clinics, ensuring efficiency, comfort, and improved patient care. By offering reliable equipment and professional service backup, we help clinics save valuable time while enhancing the quality of service delivered to their patients.
Beyond equipment supply and maintenance, Earn Will Creation Limited also offers professional consultation for new clinic setups and relocation projects. With our experience and dedication, we aim to be a trusted partner in supporting healthcare providers to achieve operational excellence and deliver superior patient experiences.
Advanced Ophthalmic Innovations Pte Ltd
Company Profile:
Redefining Glaucoma Care
Advanced Ophthalmic Innovations Pte Ltd (AOI), a MedTech company headquartered in Singapore, is dedicated to transforming glaucoma treatment through targeted innovation with clinical excellence. Established in 2014 to address unmet needs in glaucoma therapy, AOI combines deep clinical insight with rigorous quality systems to deliver therapeutic solutions that improve long-term patient outcomes. As an ISO 13485-certified organization; we design, develop, and manufacture glaucoma treatment solutions that meet the global standards for safety, performance, and reliability.
At the heart of our product portfolio is the PAUL® Glaucoma Implant, a next-generation glaucoma drainage device designed to regulate intraocular pressure and slow disease progression. The PAUL® implant incorporates several innovative design features – including a micro-sized tube to reduce early hypotony risk and an optimized endplate for aqueous filtration while minimizing anatomical disruption – all constructed from flexible, medical-grade silicone for enhanced surgical handling and patient safety.
Driven by a commitment to advancing global glaucoma care, AOI has successfully obtained regulatory approvals that have enabled the PAUL® implant’s use across a growing international footprint. Today, it is recognized and utilized by ophthalmic surgeons in more than 60 countries worldwide.
With an emphasis on innovation, quality, and patient-centric design, AOI continues to expand the frontiers of glaucoma treatment – offering hope and improved quality of life to those affected by this sight-threatening disease.
Gaush Meditech ltd
Company Profile:
Gaush Meditech ltd is a company committed to advancing patients’eye health. With more than 20 years of development, Gaush provides customers with integrated product and service
offering business covering R&D, manufacturing, sales, training, and technical services of
ophthalmic devices.Gaush was successfully listed on the main board of the Stock Exchange of
Hong Kong on December 12, 2022.
With continuous expansion, Gaush has achieved a rich product portfolio that covers all 4 major
dimensions of ophthalmic devices (diagnosis, treatment, instruments, consumables). With more
than 120 types of products, Gaush aims at addressing the various needs of ophthalmologists and
patients in 7 sub-specialties of eye health (Retinal Disease, Cataract, Glaucoma, Refractive
Surgery, Optometry, Ocular Surface / Corneal Disease, and Pediatric Ophthalmology).
Professionalism, integrity, and accountability form the basis of the long-term cooperation between
Gaush and international brand partners. Sixteen globally influential ophthalmic players from
Germany, US etc. have established exclusive partnerships with Gaush for China market.
Gaush has also created its strong network of sales distribution after years of growth. We sell our
products to over 4000 end customers in China, Hong Kong and Macau, including 1000+ Class III hospitals.

